top of page
Search

How Generative AI is Easing the Burnout Crisis Among Oncologists

  • Writer: Gokul Rangarajan
    Gokul Rangarajan
  • Nov 10
  • 14 min read

Not just AI, but automating workflows and patient management to bring back balance, empathy, and efficiency in cancer care.


Oncology Insight


India’s oncologists are facing an unprecedented workload crisis — with each specialist managing between 475 to 1,000 patients a year, and nearly 37% experiencing moderate to severe burnout. Despite the growing cancer burden, over 90% of oncologists are concentrated in urban areas, leaving rural patients underserved and specialists overstretched. Compounding the issue, only 28% of cancer centers use full-fledged digital EMR systems, limiting the ability to streamline care or collaborate effectively.

Each year has 14L to 15L new patients, and we have only 3000-4000 Oncologists
Each year has 14L to 15L new patients, and we have only 3000-4000 Oncologists

This blog explores how Generative AI and intelligent workflow automation can help close these critical gaps, from automating repetitive documentation to improving diagnostic accuracy and patient communication. By integrating AI into oncology operations, hospitals can reduce administrative fatigue, improve care quality, and restore the human focus of cancer treatment.




The Oncologist’s Knowledge Burden in a Fast-Evolving Field
Modern oncology is advancing faster than any other clinical discipline. Every week brings a new study, molecule, or trial update in immunotherapy, CAR-T, bispecifics, and AI-driven diagnostics. Yet, for the average oncologist managing 40–60 patients a day, keeping pace with this information explosion is nearly impossible. Over 250 new cancer papers are published daily worldwide, but only a fraction ever reach the clinic.


The Pace of Change in Oncology


Worldwide, the number of cancer-related research papers now exceeds 40,000 annually, adding hundreds of new findings every week. Each year, between 3,000 and 6,000 new clinical trials are registered globally, and thousands more are published


interim or final results. Within just one field precision oncology thousands of peer-reviewed studies emerge yearly; one review alone identified 709 new AI-based precision medicine papers in a single year. Regulatory activity is equally intense: the U.S. FDA approves 13–66 new oncology drugs, indications, or molecular entities each year, while ongoing drug shortages (18–29% oncology-related) complicate treatment access and planning. In such an environment, even the most dedicated oncologists cannot realistically track all the new discoveries, therapies, and trial outcomes.


Average Oncologists form India typically work 40–70 hours per week, with less than 30–45 minutes of free time daily for self-learning or research. Given that it takes about 4–6 hours per week just to review major oncology updates, most clinicians can realistically read <10% of new findings. The result: even highly motivated oncologists struggle to stay current amid a flood of 40,000+ new cancer papers and dozens of new drug approvals each year a widening gap between discovery and day-to-day practice.


  • Clinical trials: Over 2,100 new oncology trials globally across all major fields; solid tumors and hematology trials dominate.​

  • Peer-reviewed studies: Medical oncology drives publication volume (>10,000), with major subspecialties also highly active.​

  • Regulatory actions: About 65–70 major new oncology approvals (drugs, indications, procedures) globally per year; highest in solid tumor and precision/immuno-oncology.​

  • New surgical/therapy/process: Robotics, AI, image-guided tech, new protocols, and pharmaceuticals each bring ~5–20 notable annual innovations (some cross fields).​


Within just one field precision oncology thousands of peer-reviewed studies emerge yearly; one review alone identified 709 new AIhe rate of knowledge growth has outpaced human capacity for continuous learning, making AI-driven summarization and insight systems no longer optional but essential for clinical relevance and quality care.


Research updates on Oncology each year
Research updates on Oncology each year



AI Powered oncology Insights
AI Powered oncology Insights


Weekly Oncology Intelligence Summary

It’s now easy to generate oncology research summaries using Gen AI, saving 4–6 hours a week that oncologists usually spend tracking papers and approvals. By connecting tools like ChatGPT, Gemini, and Perplexity to trusted data feeds such as PubMed, JCO, ClinicalTrials.gov, and FDA updates, you can automatically receive structured, verified weekly reports on trials, therapies, and regulations. In the next section, we’ll show how to use these tools together to create consistent, real-time oncology intelligence updates with minimal setup.

This prompt automates the weekly monitoring of global oncology research and regulatory activity, producing a single, structured intelligence brief every Saturday at 5 PM IST. It saves oncologists and research managers from manually tracking hundreds of new studies, clinical trials, and approvals each week by consolidating verified updates into one concise report. The output is a clearly formatted summary—with exact URLs, publication dates, and short factual abstracts for each item—organized into eight sections (Clinical Trials, Peer-Reviewed Studies, White Papers, Epidemiology, Regulatory Actions, New Tools, New Therapies, and Key Takeaways). Used regularly, it can save 5–7 hours of screening time per week, reduce information overload, and ensure decision-makers remain current with the latest oncology insights without interrupting their clinical or academic workflow.


Sample Prompt 1 Simple 


You are a senior oncology research analyst: weekly (past 7 days) gather and summarize major oncology updates (clinical trials, peer-reviewed studies, preprints, epidemiology, regulatory actions, new tools/procedures, and therapies).
For each item provide: Title, 2–4 sentence Summary, Date, and the exact source URL (direct article/trial link).
 Organize into sections (Clinical Trials; Peer-Reviewed Studies; White Papers/Preprints; Epidemiology; Regulatory Actions; New Tools/Procedures; New Therapies; Key Takeaways).
Use trusted sources (PubMed, ClinicalTrials.gov, JCO, Nature Oncology, JAMA Oncology, medRxiv, FDA/EMA/CDSCO, OncLive, ESMO, etc.) and fetch new items, not homepages.
 Output clean Markdown and export a structured Excel/CSV (Category | Title | Summary | Date | Source URL) with clickable links.
 Schedule: run automatically every Saturday at 17:00 IST.

Sample Prompt 2 Advanced 

System Role: You are a senior oncology research analyst and scientific writer who produces weekly evidence-based intelligence reports for oncologists, researchers, and investors.
 Your task is to gather and summarize all major oncology updates from the past 7 days, from trusted and peer-reviewed sources only.
Objective: Create a Weekly Oncology Intelligence Summary that captures the most relevant and verifiable developments across oncology research, clinical trials, regulatory activity, and therapeutic innovation.
Each summary item must include:
Title (precise and descriptive)
Summary (2–4 sentences, factual and non-promotional)
Date (publication or posting date)
Exact Source URL (direct link to the study, press release, or regulatory notice — not the homepage)
Structure of the Output
Header
This Week in Oncology: [Start Date – End Date] Compiled on: [Date of Report]
1. Clinical Trials
Summarize 5–10 newly posted, updated, or completed oncology clinical trials.
 Each entry should include:
Title of trial or NCT ID
Trial phase and indication
Key findings or endpoints (if available)
Date and direct ClinicalTrials.gov or publication link
Example: Title: Phase 2 CAR-T Trial Shows 78% Response in Relapsed Lymphoma   Summary: A multicenter Phase 2 trial (NCT05671234) reported a 78% overall response rate in patients with relapsed DLBCL treated with a next-generation CD19 CAR-T product. Results suggest improved persistence compared with earlier generations.   Date: November 5, 2025   Source: https://clinicaltrials.gov/study/NCT05671234
2. Peer-Reviewed Journals / Studies: List 10–15 new research papers, meta-analyses, or reviews published this week in major oncology journals.
 Each should include:
Journal name (e.g., Nature Cancer, JCO, Lancet Oncology, JAMA Oncology)
Study topic, population, and primary result
Direct DOI or article URL
Date of publication
Example:
Title: Dual Checkpoint Blockade Improves Survival in Advanced Melanoma   Summary: A *Nature Cancer* study found that PD-1 + LAG-3 inhibition improved median overall survival by 3.8 months compared with PD-1 alone.   Date: November 7, 2025   Source: https://www.nature.com/articles/s41586-025-01832-0
3. White Papers / Preprints
Include recent institutional or preprint findings from:
medRxiv
bioRxiv
WHO, NCI, or ESMO white papers
Each entry should summarize the topic and provide the exact preprint link and posting date.
4. Patient Pool / Epidemiology
Add updates on:
Global or regional cancer incidence
Mortality statistics
Screening trends or registry data
Include citation or registry link (e.g., WHO, IARC, NCDIR).
5. Regulatory Actions
Summarize 5–10 oncology-related regulatory decisions from:
FDA
EMA
CDSCO (India)
MHRA (UK)
Include:
Drug or device name
Indication
Decision type (approval, label update, withdrawal, etc.)
Date and direct FDA/EMA/CDSCO link
Example:
Title: FDA Approves Daratumumab and Hyaluronidase for High-Risk Smoldering Multiple Myeloma   Summary: FDA expanded the indication for Darzalex Faspro (daratumumab + hyaluronidase) to treat adults with high-risk smoldering myeloma, marking a shift toward earlier intervention.   Date: November 6, 2025   Source: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daratumumab-and-hyaluronidase-fihj-high-risk-smoldering-multiple-myeloma
6. New Tools / Procedures
List any new:
Imaging technologies (MRI/PET)
Radiation planning systems
AI diagnostics or robotics updates
Minimally invasive surgical tools
Each entry: 2–3 lines with source link and date.
7. New Therapies / Drugs
Include announcements or publications about:
New drug launches
CAR-T / TCR-T approvals
Bispecifics and antibody-drug conjugates (ADCs)
Combination therapy breakthroughs
Each should include molecule name, mechanism, indication, trial/approval data, and direct URL.
8. Key Takeaways
End with a short 5–7 line summary highlighting:
Main research trend of the week
Top disease area(s) with new activity
Regulatory highlights
AI / precision-medicine relevance
Implications for clinicians and researchers
Source Databases to Search
(Use these each week — fetch new results, not homepages)
PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=oncology&sort=date
Google Scholar (Oncology filter): https://scholar.google.com/
ClinicalTrials.gov: https://clinicaltrials.gov/
JAMA Oncology: https://jamanetwork.com/
ASCO Journal of Clinical Oncology (JCO): https://ascopubs.org/journal/jco
International Journal of Oncology: https://www.spandidos-publications.com/ijo
Karger Oncology: https://karger.com/ocl
Nature Oncology: https://www.nature.com/subjects/oncology
ESMO Oncology News: https://www.esmo.org/newsroom/oncology-news
OncLive: https://www.onclive.com/
Oncology News Central: https://www.oncologynewscentral.com/
OncoDaily: https://oncodaily.com/
FDA Approvals Database: https://www.fda.gov/drugs/drug-approvals-and-databases
EMA News: https://www.ema.europa.eu/en/news
medRxiv Oncology: https://www.medrxiv.org/search/oncology
Formatting Rules
Use clean text or Markdown format
Each section labeled clearly
Each item must have:
Title:
Summary:
Date:
Source: (exact article or trial URL)

Prompt 3: Pro


{ "name": "Weekly Oncology Intelligence Summary", "system_role": "You are a senior oncology research analyst and scientific writer who produces weekly evidence-based intelligence reports for oncologists, researchers, and investors.", "objective": "Gather and summarize all major oncology updates from the past 7 days from trusted and peer-reviewed sources only. Produce a concise, verifiable, and automation-ready weekly brief.", "requirements": { "item_fields": [ "Title (precise and descriptive)", "Summary (2–4 sentences, factual and non-promotional)", "Date (publication or posting date)", "Exact Source URL (direct link to the study, press release, trial entry, or regulatory notice — not the homepage)" ], "scope": "Clinical trials, peer-reviewed studies, preprints/white papers, epidemiology, regulatory actions, new tools/procedures, new therapies/drugs", "quality": "Prefer primary sources (journal article DOI, ClinicalTrials.gov NCT, FDA/EMA/CDSCO pages, medRxiv/bioRxiv entries). Avoid press-only or secondary summaries unless primary link unavailable." }, "output_structure": { "header": [ "This Week in Oncology: [Start Date – End Date]", "Compiled on: [Date of Report]" ], "sections": { "Clinical Trials": { "items_required": "5–10", "fields": [ "Title (or NCT ID)", "Trial phase and indication", "Key findings or endpoints (if available)", "Date", "Exact ClinicalTrials.gov or publication URL" ] }, "Peer-Reviewed Journals / Studies": { "items_required": "10–15 (if available)", "fields": [ "Article title", "Journal name", "Study topic, population, primary result", "Publication date", "Direct DOI or article URL" ] }, "White Papers / Preprints": { "items_required": "3–7 (if available)", "fields": [ "Title", "Source (medRxiv / bioRxiv / agency)", "Short summary", "Posting date", "Exact preprint/white paper URL" ] }, "Patient Pool / Epidemiology": { "items_required": "1–4", "fields": [ "Statistic or trend headline", "Region/population context", "Date", "Source link (WHO / IARC / registry / paper)" ] }, "Regulatory Actions": { "items_required": "5–10 (if available)", "fields": [ "Drug/device name", "Indication", "Decision type (approval/label update/warning/withdrawal)", "Date", "Direct regulator URL (FDA/EMA/CDSCO/MHRA)" ] }, "New Tools / Procedures": { "items_required": "3–7", "fields": [ "Tool or procedure name", "Short description / use-case", "Evidence or release note summary", "Date", "Exact source URL" ] }, "New Therapies / Drugs": { "items_required": "3–7", "fields": [ "Molecule / therapy name", "Mechanism and indication", "Trial/approval data summary", "Date", "Exact URL" ] }, "Key Takeaways": { "items_required": "1", "fields": [ "5–7 line summary of main trends, top disease areas, regulatory highlights, AI/precision relevance, and implications for clinicians/researchers" ] } } }, "source_databases": [ "https://pubmed.ncbi.nlm.nih.gov/?term=oncology&sort=date", "https://scholar.google.com/", "https://clinicaltrials.gov/", "https://jamanetwork.com/", "https://ascopubs.org/journal/jco", "https://www.spandidos-publications.com/ijo", "https://karger.com/ocl", "https://www.nature.com/subjects/oncology", "https://www.esmo.org/newsroom/oncology-news", "https://www.onclive.com/", "https://www.oncologynewscentral.com/", "https://oncodaily.com/", "https://www.fda.gov/drugs/drug-approvals-and-databases", "https://www.ema.europa.eu/en/news", "https://www.medrxiv.org/search/oncology" ], "formatting_rules": { "format": "clean Markdown or plain text", "per_item_format": [ "Title:", "Summary:", "Date:", "Source: (exact article/trial/regulatory URL)" ], "sections_labeled": true }, "automation_instructions": { "frequency": "Weekly", "schedule": "Every Saturday at 17:00 IST", "deliverables": [ "Text/Markdown weekly brief", "Structured Excel/CSV file with columns: Category | Title | Summary | Date | Source URL" ], "export_details": "Include clickable hyperlinks in Excel/CSV. Save/upload to designated Notion/Drive folder and send notification email." }, "optional_extension": "At the end of each run, export the compiled oncology summary into a downloadable Excel file with columns (Category, Title, Summary, Date, Source URL) and include all links as clickable hyperlinks.", "notes": [ "Always prefer exact URLs (DOI landing page, ClinicalTrials.gov study page, FDA/EMA/CDSCO press release or label page, medRxiv/bioRxiv preprint link).", "If a primary URL is paywalled, include the DOI and a reliable secondary link (publisher abstract or PubMed).", "Flag items that require clinical verification or expert review (e.g., preprints, early-phase trials without peer-reviewed results)." ] }

Custom Prompts 
You can customize this prompt for any oncology specialty—medical, surgical, radiation, or pediatric—by editing the “role,” “goal,” and “sources” fields in the JSON; simply replace general oncology terms with your subspecialty focus, and add or remove journal URLs (e.g., Annals of Surgical Oncology, Radiotherapy and Oncology, Blood Journal) to refine outputs for that domain.


  • Objective: Explains what the report should accomplish. Modify this if you want the summary to target a narrower field such as immunotherapy, pediatric cancers, or radiation techniques.

  • Requirements: Lists what data fields appear in each item. Add or remove elements like “Impact Level,” “Trial Phase,” or “Study Region” to capture more or less detail.

  • Structure: Organizes the sections (clinical trials, studies, regulatory actions, etc.). You can add a new block—for example, “AI in Oncology Tools”—or delete sections irrelevant to your workflow.

  • Sources: Contains journal and database URLs. Replace, add, or remove links depending on your information needs—e.g., add Annals of Surgical Oncology for surgical focus or Blood Journal for hematology.

  • Format: Controls how results appear (Markdown, Excel, CSV). Change it if you prefer different output types or column headers.

  • Automation: Manages timing and delivery. Adjust frequency (daily, weekly), output location (Google Drive, email), or delivery method (Slack, website).

  • Rules: Maintains data quality and reliability. Edit this to tighten validation (e.g., “include only peer-reviewed Phase 3 data”) or to broaden acceptance of preprints for faster updates.

Within just one field precision oncology thousands of peer-reviewed studies emerge yearly; one review alone identified 709 new AIhe rate of knowledge growth has outpaced human capacity for continuous learning, making AI-driven summarization and insight systems no longer optional but essential for clinical relevance and quality care.


Advanced Workflow: From Text to Email, Web, and Audio Automation is useful because it eliminates the need for manual data gathering, summarizing, and sharing, saving several hours each week. Once set up, it can automatically collect oncology updates, generate summaries, and deliver them through your preferred channel. You can configure it to email formatted reports to oncologists, send WhatsApp messages with key highlights using Twilio integration, or connect with Google LLM (Gemini) to post insights into a shared Google Doc or dashboard. This ensures real-time, consistent knowledge delivery without human intervention, keeping your oncology team continuously informed.


Once your Weekly Oncology Intelligence Summary JSON prompt is generating consistent reports, you can customize its presentation and delivery easily.To change fonts and style for visual reports, export the Markdown output into Google Docs or Notion, then apply your preferred fonts (e.g., Roboto, Open Sans, Montserrat) and branding using templates. You can automate this conversion via Zapier (“Create Google Doc from Markdown”). From there, the workflow continues automatically: Email Delivery – Attach the formatted PDF or Doc and send via Gmail or Outlook every Saturday 5 PM using Zapier or Make. Web Publication – Push the same file to your hospital website, Notion public page, or Medium blog using API integrations. Audio Summary / Podcast – Use Google Cloud Text-to-Speech, Play.ht, or ElevenLabs to convert the summary into a short audio brief; these can auto-upload to Spotify or your internal learning portal as a 2-minute oncology podcast.This approach turns a single AI-generated summary into a multichannel weekly knowledge broadcast—readable, shareable, and listenable—while requiring zero manual work after setup.



Common building blocks (applies to all platforms)

• Fetch sources: PubMed/ClinicalTrials RSS or API, journal RSS (Nature/JCO), medRxiv RSS, ClinicalTrials.gov RSS or API, FDA/EMA news RSS.• LLM prompt: Use the structured JSON prompt you created. Inputs: fetched items (title + link + date + short excerpt). Output: Markdown weekly brief + CSV rows. Edit prompt sources/focus by changing the sources list and "role/goal" fields.• Storage: Google Drive / Google Sheets / Notion for archive and Excel export.• TTS: Google Cloud Text-to-Speech, ElevenLabs, or Play.ht to render audio MP3.• WhatsApp: Twilio WhatsApp API (register sender number).• Scheduling: Cron nodes (n8n), scheduler in Zapier, Opal schedule/action.



n8n Automation workflow
n8n Automation workflow Sheet


A. n8n workflows

1) Weekly Email Summary (n8n)

Nodes sequence:

  1. Cron — run every Saturday 17:00 IST.

  2. HTTP Request / RSS Read — pull RSS from PubMed, ClinicalTrials.gov, JCO, Nature, medRxiv. (Aggregate newest items last 7 days.)

  3. Function — normalize items into JSON array (title, excerpt, url, date, source).

  4. HTTP Request (LLM) — call OpenAI/GPT with your structured prompt and the JSON array as context. Receive Markdown summary + CSV.

  5. Google Drive (Create File) — save Markdown and export CSV/Excel.

  6. Gmail / SMTP Send — attach PDF/Markdown/Excel, send to recipient list. Email subject: “Weekly Oncology Update — [date range]”.Where to edit: Cron node schedule; RSS URLs in HTTP node; recipients in Gmail node; prompt in LLM node.

Notes: Use Google Drive PDF conversion if you want branded fonts (create Google Doc from Markdown then export PDF).

2) Daily WhatsApp Highlight (n8n)

Nodes sequence:

  1. Cron — run daily at preferred time.

  2. HTTP Request / RSS Read — fetch last 24h items.

  3. Filter / Function — pick top 3 highest-priority items by source or keyword (e.g., FDA, CAR-T, approval).

  4. HTTP Request (LLM) — prompt: “Create a 3-bullet WhatsApp message summarizing these 3 items in plain text, include source URLs.”

  5. Twilio (WhatsApp) Send Message — send message to list of phone numbers (or group).Where to edit: Cron schedule; ranking/filter logic; Twilio credentials and phone recipients; prompt templates.

Notes: Keep messages short (2–3 bullets). For groups, send to single group number or iterate recipients.

3) Weekly Audio Summary / Podcast (n8n)

Nodes sequence:

  1. Cron — same weekly trigger as email.

  2. HTTP Request / RSS — gather weekly items.

  3. LLM — produce a spoken-word script (2–4 minute summary) using a prompt: “Convert the weekly brief into a 2–3 minute spoken script suitable for podcast, natural tone.”

  4. TTS (Google Cloud TTS / ElevenLabs) — convert script to MP3.

  5. Google Drive / S3 Upload — store MP3.

  6. Optional: Podcast publish API (Libsyn, Anchor) or create post to website / Notion and attach MP3.

  7. Gmail / Slack — notify subscribers with link to MP3.Where to edit: script prompt; TTS voice selection; storage/publishing target.

Notes: Add ID3 metadata when uploading for podcast clients. Automate show notes using the LLM output.

B. Opal workflows


(Opal = workflow/automation layer that supports scheduled prompts and multi-channel outputs)

1) Weekly Email Summary (Opal)

Steps:

  1. Schedule Job — weekly Saturday 17:00 IST.

  2. Source Connectors — enable PubMed/medRxiv/ClinicalTrials connectors or RSS ingestion list.

  3. Transform — simple transformation: dedupe and extract fields.

  4. LLM Task — apply your JSON prompt to produce Markdown + CSV.

  5. File Output — save to integrated storage (Drive/Opal storage).

  6. Email Task — send summary and attach CSV to recipients.Edit points: connectors list, schedule, recipients, branding template.

2) Daily WhatsApp (Opal)

Steps:

  1. Schedule Job — daily.

  2. Ingest — last-24h items.

  3. LLM Short Summary — create short 3-bullet text.

  4. Twilio Task — send via WhatsApp.Edit: adjust priority rules and recipient list in the job config.

3) Weekly Audio Summary (Opal)

Steps:

  1. Run weekly job — ingest items.

  2. LLM — script generation.

  3. TTS integration — convert and store audio.

  4. Publish — post to your site or Opal-hosted page and email link.Edit: TTS voice, script length settings, publish target.

C. Zapier workflows

1) Weekly Email Summary (Zapier)

Zap steps:

  1. Schedule by Zapier — every Saturday 17:00 IST.

  2. RSS by Zapier — multiple RSS feeds (PubMed, medRxiv, JCO).

  3. Code by Zapier (JavaScript) — aggregate and format items into JSON array.

  4. OpenAI (GPT) — pass prompt + data, get Markdown + CSV.

  5. Google Drive — Create File — save Markdown & CSV.

  6. Gmail — Send Email — attach CSV and link to Drive file; recipients list.Edit: feeds in RSS step; recipients in Gmail step; prompt in OpenAI step.

Notes: Zapier has execution limits — batch items or limit number of feeds.

2) Daily WhatsApp (Zapier + Twilio)

Zap steps:

  1. Schedule — daily.

  2. RSS — filter — only items matching keywords (FDA, approval, CAR-T).

  3. OpenAI — short 3-bullet text.

  4. Twilio — Send WhatsApp Message — send per recipient.Edit: filter keywords and recipients.

3) Weekly Audio Summary (Zapier)

Zap steps:

  1. Schedule — weekly.

  2. RSS aggregation → OpenAI for script.

  3. Text-to-Speech (Cloud TTS or Zapier app) — produce MP3.

  4. Google Drive Upload and Email notification.Edit: voice selection, file naming, email recipients.

Change sources — update RSS/API URLs in the fetch node.• Narrow specialty — replace “role/goal” in LLM prompt to “medical oncology” or “surgical oncology.”• Change cadence — edit Cron / Scheduler node.• Add/remove recipients — edit Gmail/Twilio recipient fields.• Adjust priority rules — change filter/function node logic that selects top items.• Switch TTS provider — edit TTS node credentials and voice parameter.


Oncologists Summarizing using AI
Oncologists should use more of Ai tools


In conclusion, the convergence of AI systems like ChatGPT, Gemini, and Perplexity with workflow automation tools such as n8n, Opal, and Zapier is redefining how oncology professionals manage research intelligence. These integrated workflows automatically collect, summarize, and deliver weekly updates on clinical trials, regulatory actions, and emerging therapies transforming hours of manual data review into a few minutes of curated insight. By using n8n for multi-source orchestration, Opal for AI-driven scheduling, and Zapier for automated email and Drive reporting, oncologists can maintain a continuous flow of verified information with zero manual effort. This marks a practical evolution where AI and workflow automation together support precision learning and faster decision-making in oncology.



Looking ahead, the incorporation of quantum computing will take this one step further. Quantum algorithms could process complex clinical datasets, molecular simulations, and trial correlations exponentially faster, enhancing the AI’s ability to predict treatment responses and detect new therapeutic targets. When quantum computing and generative AI converge inside these workflow ecosystems, oncology intelligence will move from reactive information gathering to predictive, simulation-based insight generation  enabling truly data-driven precision medicine at scale.

Links Cited



This blog is written in collaboration between Pitchworks VC Studio and leading oncology associations across the world, including the (AOSRTIC) and the (TOOS). The insights and workflows presented are grounded in data drawn from WHO Cancer Databases, Cancer.org, and partnerships with various international research organizations. Together, this collaborative effort aims to demonstrate how AI, automation, and emerging quantum computing technologies can reshape oncology research, streamline global information sharing, and empower clinicians with timely, validated intelligence for improved cancer care outcomes.


Comments

bottom of page